Blood Spot Tests
An essential, yet often little-known, procedure that can have a profound impact on a child’s future – “baby blood spot testing.”
This simple test plays a crucial role in safeguarding the health and well-being of new borns.
Baby Blood Spot Testing: A Lifesaver in the First Days of Life
What is Baby Blood Spot Testing?
A small blood sample is typically collected from a baby’s heel, dried on a special filter paper, and sent to a laboratory for analysis. This test screens for a range of inherited and potentially life-threatening medical conditions, often before symptoms appear.
- Metabolic Disorders: Conditions such as phenylketonuria (PKU), maple syrup urine disease (MSUD), and galactosemia are screened for. Early diagnosis allows for dietary modifications and medical interventions that can prevent developmental problems.
- Endocrine Disorders: Congenital hypothyroidism, a condition where the thyroid gland doesn’t produce enough thyroid hormones, is routinely screened. Early treatment can prevent intellectual disability.
- Hemoglobin Disorders: Sickle cell disease and other hemoglobinopathies are screened for, allowing early intervention and management.
- Cystic Fibrosis: This genetic disorder can be identified through newborn screening, enabling early treatment to improve quality of life.
- Hearing Loss: Some newborn screening programs include hearing tests to identify hearing impairments early.
Early Detection Saves Lives
The beauty of baby blood spot testing lies in its potential to detect these conditions before they cause any noticeable symptoms. By identifying these conditions in the first days of life, healthcare providers can intervene promptly, preventing or minimising the adverse effects of these disorders. For many of the conditions screened, early diagnosis and treatment can make a profound difference in a child’s health and development.
So… just what are LEBBS doing?
Annually, south Lincolnshire can expect 5,500 new births, while the north of the county can expect 4,500 new births. That’s almost 10,000 babies being born across Lincolnshire in any year, all requiring Blood Spot Tests and needing a reliable and gauranteed delivery service (and return) of test results to and from the Sheffield Childrens Hospital.
From December 4th 2023, for a period of 5 weeks, LEBBS are working with the ULHT (United Lincolnshire Health Trust) and NLAG (North Lincolnshire and Goole FT) to ensure tests can be sent without delay and fear of loss in transit to the Sheffield Children’s Hospital for rapid analysis and a return to the Lincolnshire hospital from where any test was requested.
The journey will be made 3 days each week (Mon, Wed & Fri) from Boston – Grantham – Lincoln (a 240 mile round trip) and Goole – Grimsby – Scunthorpe (a 192 mile round trip), two members of the LEBBS team will meet and handover these tests for onward delivery to, and return from, Sheffield.
For the 5 week period, this commitment will result in almost 3,800 miles travelled.
More information on ULHT’s work can be found on the ULHT website here.
More information and all your questions about newborn blood spot screening answered, including what happens to your baby’s blood spot card, can be found on the NHS website here.